In search of a target: PD-1 and PD-L1 profiling across glioma types

被引:15
作者
Berghoff, Anna S. [1 ,2 ,3 ]
Preusser, Matthias [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[2] Med Univ Vienna, Comprehens Canc Ctr CNS Unit CCC CNS, Vienna, Austria
[3] German Canc Res Ctr, German Canc Consortium DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany
关键词
TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PROGNOSTIC IMPACT; GLIOBLASTOMA; EXPRESSION; BLOCKADE; CANCER; CELLS;
D O I
10.1093/neuonc/now162
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:1331 / 1332
页数:2
相关论文
共 13 条
[1]
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma [J].
Berghoff, Anna Sophie ;
Kiesel, Barbara ;
Widhalm, Georg ;
Rajky, Orsolya ;
Ricken, Gerda ;
Woehrer, Adelheid ;
Dieckmann, Karin ;
Filipits, Martin ;
Brandstetter, Anita ;
Weller, Michael ;
Kurscheid, Sebastian ;
Hegi, Monika E. ;
Zielinski, Christoph C. ;
Marosi, Christine ;
Hainfellner, Johannes A. ;
Preusser, Matthias ;
Wick, Wolfgang .
NEURO-ONCOLOGY, 2015, 17 (08) :1064-1075
[2]
Bouffet E., 2016, J Clin Oncol
[3]
Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma [J].
Darb-Esfahani, Silvia ;
Kunze, Catarina Alisa ;
Kulbe, Hagen ;
Sehouli, Jalid ;
Wienert, Stephan ;
Lindner, Judith ;
Budczies, Jan ;
Bockmayr, Michael ;
Dietel, Manfred ;
Denkert, Carsten ;
Braicu, Ioana ;
Joehrens, Korinna .
ONCOTARGET, 2016, 7 (02) :1486-1499
[4]
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies [J].
Garber, Sarah T. ;
Hashimoto, Yuuri ;
Weathers, Shiao-Pei ;
Xiu, Joanne ;
Gatalica, Zoran ;
Verhaak, Roel G. W. ;
Zhou, Shouhao ;
Fuller, Gregory N. ;
Khasraw, Mustafa ;
de Groot, John ;
Reddy, Sandeep K. ;
Spetzler, David ;
Heimberger, Amy B. .
NEURO-ONCOLOGY, 2016, 18 (10) :1357-1366
[5]
Lim Michael, 2016, Am Soc Clin Oncol Educ Book, V35, pe132, DOI 10.14694/EDBK_159084
[6]
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [J].
Louis, David N. ;
Perry, Arie ;
Reifenberger, Guido ;
von Deimling, Andreas ;
Figarella-Branger, Dominique ;
Cavenee, Webster K. ;
Ohgaki, Hiroko ;
Wiestler, Otmar D. ;
Kleihues, Paul ;
Ellison, David W. .
ACTA NEUROPATHOLOGICA, 2016, 131 (06) :803-820
[7]
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells [J].
Mahoney, Kathleen M. ;
Sun, Heather ;
Liao, Xiaoyun ;
Hua, Ping ;
Callea, Marcella ;
Greenfield, Edward A. ;
Hodi, F. Stephen ;
Sharpe, Arlene H. ;
Signoretti, Sabina ;
Rodig, Scott J. ;
Freeman, Gordon J. .
CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) :1308-1315
[8]
PD-L1 expression and prognostic impact in glioblastoma [J].
Nduom, Edjah K. ;
Wei, Jun ;
Yaghi, Nasser K. ;
Huang, Neal ;
Kong, Ling-Yuan ;
Gabrusiewicz, Konrad ;
Ling, Xiaoyang ;
Zhou, Shouhao ;
Ivan, Cristina ;
Chen, Jie Qing ;
Burks, Jared K. ;
Fuller, Greg N. ;
Calin, George A. ;
Conrad, Charles A. ;
Creasy, Caitlin ;
Ritthipichai, Krit ;
Radvanyi, Laszlo ;
Heimberger, Amy B. .
NEURO-ONCOLOGY, 2016, 18 (02) :195-205
[9]
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma? [J].
Preusser, Matthias ;
Berghoff, Anna S. ;
Wick, Wolfgang ;
Weller, Michael .
CLINICAL NEUROPATHOLOGY, 2015, 34 (06) :313-321
[10]
Prospects of immune checkpoint modulators in the treatment of glioblastoma [J].
Preusser, Matthias ;
Lim, Michael ;
Hafler, David A. ;
Reardon, David A. ;
Sampson, John H. .
NATURE REVIEWS NEUROLOGY, 2015, 11 (09) :504-514